Cargando…
Prostate cancer survivorship care: if not now, when?
Autores principales: | Dunn, Jeffrey, Heathcote, Peter, Chambers, Suzanne K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252711/ https://www.ncbi.nlm.nih.gov/pubmed/33565238 http://dx.doi.org/10.1111/bju.15358 |
Ejemplares similares
-
Prostate cancer survivorship essentials framework: guidelines for practitioners
por: Dunn, Jeff, et al.
Publicado: (2020) -
Large variation in conservative management of low‐risk prostate cancer in Australia and New Zealand
por: Ong, Wee Loon, et al.
Publicado: (2022) -
High prostate‐specific membrane antigen (PSMA) positron emission tomography (PET) maximum standardized uptake value in men with PI‐RADS score 4 or 5 confers a high probability of significant prostate cancer
por: Ptasznik, Gideon, et al.
Publicado: (2022) -
Pathological predictors of (18)F‐DCFPyL prostate‐specific membrane antigen‐positive recurrence after radical prostatectomy
por: Perry, Elisa, et al.
Publicado: (2022) -
Event‐free survival after radical prostatectomy according to prostate‐specific membrane antigen‐positron emission tomography and European Association of Urology biochemical recurrence risk groups
por: Roberts, Matthew J., et al.
Publicado: (2022)